Janus kinase inhibitors (JAKi) carry a class-wide boxed warning for major adverse cardiovascular events; however, stress-induced cardiomyopathy has not been previously reported with upadacitinib. A 64-year-old woman with Crohn's disease and high-output ileostomy was initiated on upadacitinib 45 mg daily. Six days later, she developed new left ventricular systolic dysfunction (ejection fraction 35%) with mid-to-apical wall motion abnormalities. Coronary angiography showed nonobstructive disease, and cardiac magnetic resonance imaging demonstrated normalization of biventricular function without fibrosis or infarction, consistent with Takotsubo cardiomyopathy. Naranjo scoring indicated a possible adverse drug reaction (score 3). This first reported case of Takotsubo cardiomyopathy temporally associated with upadacitinib, alongside previous reports with tofacitinib and ruxolitinib, suggests a potential JAKi class-related cardiac effect. Clinicians should maintain a low threshold for cardiac evaluation in patients who develop dyspnea, edema, arrhythmias, or unexplained hemodynamic instability soon after JAKi initiation, particularly when substantial physical stressors or cardiovascular risk factors are present.
25 June 2026 in Therapeutic Hypothermia and Temperature Management
Shivering is a common complication of targeted temperature management (TTM), which could undermine its neuroprotective benefits by increasing cerebral oxygen consumption and metabolic demand. Buspirone, a 5-HT1A receptor partial agonist, is incorporated into many antishivering protocols for TTM following cardiac arrest, despite limited evidence supporting its efficacy in critically ill patients. We conducted a targeted literature review using PubMed to assess the evidence in favor of the use of buspirone in antishivering protocols during TTM. Experimental, physiological, and clinical studies were reviewed with emphasis placed on study design, patient population, and relevance to critically ill individuals undergoing TTM. Experimental studies in animals and healthy human volunteers show that buspirone can modestly lower core temperature or shivering thresholds. Two small studies ( n = 8 each) in healthy male volunteers demonstrated that buspirone reduced the shivering threshold by approximately 0.7°C. A retrospective cohort study ( n = 131) in post-cardiac arrest patients showed a reduction in shivering with a multidrug protocol including buspirone, but the independent contribution of buspirone could not be isolated. No randomized controlled trials have evaluated buspirone’s efficacy as a standalone antishivering agent in critically ill patients. Current evidence to support the buspirone’s use in antishivering protocols is limited and largely extrapolated from noncritical care settings. Given that most patients undergoing TTM already receive sedatives and analgesics with more potent antishivering effects, the incremental benefit of buspirone remains unproven. Furthermore, it adds to the already high burden of polypharmacy in ICU patients and could, in theory, increase the risk of serotonin syndrome. Randomized trials comparing protocols with and without buspirone are needed to determine its clinical utility.
An 18‐year‐old woman with congenital biliary atresia status post Kasai portoenterostomy and magnetic resonance imaging‐reported chronic liver disease presented at 32 weeks’ gestation with 6 weeks of worsening postprandial epigastric/right upper quadrant pain, nausea, and poor oral intake. Evaluation showed preserved hepatic synthetic function and no demonstrated clinically significant portal hypertension. Endoscopy excluded esophageal and gastric varices, computed tomography showed no imaging evidence of pancreatitis, biliary obstruction, or other acute intra‐abdominal pathology, computed tomography angiography excluded mesenteric ischemia, and gastric emptying scintigraphy excluded gastroparesis. Nonreassuring fetal surveillance prompted preterm induction at approximately 33 weeks 4 days. Postpartum symptoms persisted, and imaging review identified severe constipation with rectal impaction/fecalization as the dominant treatable contributor. This case broadens the peripartum phenotype reported in native‐liver biliary atresia survivors by emphasizing constipation‐associated postprandial abdominal pain, poor oral intake, nutritional risk, and medication‐related bowel dysfunction rather than variceal bleeding or hepatic decompensation alone.
Background: Multidisciplinary rounds are essential for high-quality intensive care but are frequently hindered by inconsistent team participation and logistical inefficiencies. We evaluated the associated impact of implementing a standardized multidisciplinary rounding checklist and real-time paging system on multidisciplinary team attendance, rounding efficiency, and selected clinical outcomes in the ICU. Methods: A retrospective, observational pre- and post-intervention cohort study featuring a concurrent control group was conducted at a tertiary care hospital. The study included 331 adults admitted to the medical ICU (MICU) and neurovascular critical care unit (NCCU; control). The intervention combined a standardized rounding checklist incorporating the ICU Liberation (ABCDEF) bundle and FAST HUGS BID mnemonic with a real-time paging notification system to alert team members of round start times and locations. The primary outcome was change in multidisciplinary team participation at the start and end of rounds; secondary outcomes included rounding time per patient and exploratory care-process outcomes. Results: Multidisciplinary participation at the start and conclusion of rounds significantly improved for both the MICU advanced practice provider (APP) team (p = 0.003 and p = 0.002, respectively) and the resident team (p = 0.006 and p < 0.001, respectively), while attendance in the NCCU group remained unchanged. Median rounding time per patient decreased by 20.8% (13.0 to 10.3 min, p < 0.001). In a survivor-only sensitivity analysis, the streamlined workflow decreased the median time to physical and occupational therapy consultations from 4 to 2 days (p ≤ 0.002). Invasive device stewardship significantly improved; central venous catheter utilization decreased from 58.0% to 25.0% (p < 0.001), and arterial line utilization fell from 55.0% to 26.5% (p < 0.001), with median arterial catheter duration decreasing from 5 to 3 days (p = 0.001). Conclusions: Implementing low-cost, reliable workflow standardization tools was associated with significantly improved multidisciplinary participation and shorter rounding time per patient. Favorable changes in selected care-process measures were also observed, although patient-level clinical outcomes should be interpreted as exploratory and future studies are warranted.